Celldex Therapeutics, Inc. · NASDAQ:CLDX
Kynam Capital Management, LP reported a 7.63% stake in Celldex Therapeutics, Inc. (Schedule 13G/A)
Event Dec 31, 2024 · Filed Feb 14, 2025
Kynam Capital Management, LP reported a 7.63% stake in Celldex Therapeutics, Inc., 5,064,207 shares, as a passive investor on Dec 31, 2024. Filed Feb 14, 2025 (Schedule 13G/A).
- Stake
- 7.63%
- Shares
- 5,064,207
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Kynam Capital Management, LP | 7.63% | 5,064,207 |
| Kynam Capital Management GP, LLC | 7.63% | 5,064,207 |
| Yue Tang | 7.63% | 5,064,207 |
Source
Related
- Celldex Therapeutics, Inc.
- Kynam Capital Management, LP
- Celldex Therapeutics, Inc. shareholders
- Schedule 13G/A · Kynam Capital Management, LP · Aug 14, 2026
- Schedule 13G/A · Kynam Capital Management, LP · May 15, 2026
- Schedule 13G/A · Kynam Capital Management, LP · May 15, 2025
- Schedule 13G/A · FMR LLC · Oct 7, 2026
- Schedule 13G · T. Rowe Price Associates Inc · Aug 14, 2026
- Schedule 13G/A · Bellevue Group AG · May 15, 2026
- Schedule 13G · State Street Corp · May 12, 2026
- Schedule 13G/A · FMR LLC · May 6, 2026